{"filings":[{"id":2134476,"accession_number":"0000096943-26-000097","cik":96943,"company_name":"TELEFLEX INC","ticker":"TFX","form_type":"8-K","filed_at":"2026-08-07T20:43:30+00:00","items":["8.01"],"status":"ready","headline":"Teleflex launches $250M accelerated share repurchase with Truist Bank","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["ASR with Truist Bank to repurchase $250M of common stock under existing $1B buyback program.","Initial delivery of shares equals 80% of repurchase price based on Aug 6, 2026 closing price.","Final share count based on volume-weighted average prices during ASR term, less discount.","Funded by proceeds from sale of Original Equipment Manufacturing and Development Services business.","ASR scheduled to terminate in Q4 2026, may conclude earlier at counterparty's election."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":5757783520.587611,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":2088118,"accession_number":"0000096943-26-000091","cik":96943,"company_name":"TELEFLEX INC","ticker":"TFX","form_type":"8-K","filed_at":"2026-08-06T11:08:03+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Teleflex Q2 revenue up 4.7% pro forma; cuts revenue guidance, raises adjusted EPS outlook","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q2 revenue $570.3M (+28.9% reported, +4.7% pro forma adj. constant currency); GAAP EPS $0.96, adj. EPS $1.76.","Full-year 2026 pro forma adj. constant currency revenue growth guidance reduced to 3.5%-4.5%; GAAP EPS cut to $2.54-$2.84.","Adjusted EPS guidance raised to $6.90-$7.20; includes ~19% adj. operating margin and $250M share repurchase in Q2.","Completed OEM divestiture for $1.5B cash; paid off $700M Term Loan A-2; new $500M 5.875% senior notes due 2032.","FDA approved EZPLAZ freeze-dried plasma; Freesolve BIOMAG-II enrollment completed ahead of schedule."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":5757783520.587611,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":2080318,"accession_number":"0000096943-26-000087","cik":96943,"company_name":"TELEFLEX INC","ticker":"TFX","form_type":"8-K/A","filed_at":"2026-08-05T20:44:06+00:00","items":["9.01"],"status":"ready","headline":"Teleflex completes $1.5B sale of OEM business; pro forma shows debt reduction and improved income","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Net cash proceeds of $1.5B ($1.2B after-tax) from OEM business divestiture closed Aug 3, 2026.","$700M of proceeds used to repay term A-2 loan facility; pro forma long-term debt reduced to $1.81B.","Pro forma Q1 2026 income from continuing ops of $1.9M vs reported loss of $4.8M; FY2025 pro forma income $86.9M vs $58.5M.","Ancillary agreements with buyers (Montagu/Kohlberg) for transition services up to 24 months.","Sale of Acute Care and Interventional Urology businesses remains pending."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":5757783520.587611,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":2025357,"accession_number":"0000096943-26-000084","cik":96943,"company_name":"TELEFLEX INC","ticker":"TFX","form_type":"8-K","filed_at":"2026-08-03T20:35:03+00:00","items":["2.01","7.01","9.01"],"status":"ready","headline":"Teleflex completes $1.5B sale of OEM business; plans debt paydown and share buybacks","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Sale closed Aug 3, 2026 for $1.5B cash to Montagu and Kohlberg.","After-tax proceeds estimated at ~$1.25B.","Teleflex intends to reduce debt by $800M and repurchase shares under $1B authorization.","Updated 2026 financial guidance to be provided on Aug 6, 2026.","Divestiture sharpens focus on continuing businesses and enhances financial flexibility."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":5757783520.587611,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":1059119,"accession_number":"0001193125-26-271318","cik":96943,"company_name":"TELEFLEX INC","ticker":"TFX","form_type":"8-K","filed_at":"2026-06-15T21:24:38+00:00","items":["1.01","2.03","9.01"],"status":"ready","headline":"Teleflex issues $500M of 5.875% senior notes due 2032","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["$500M aggregate principal of 5.875% senior notes due January 15, 2032; interest paid semi-annually.","Notes are unsecured senior obligations ranking pari passu with existing senior notes.","Make-whole redemption available prior to Jan 2029; then at specified premiums declining to par.","Change of control offer at 101% if notes downgraded; covenants limit liens and sale-leaseback."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":5757783520.587611,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":947796,"accession_number":"0000096943-26-000072","cik":96943,"company_name":"TELEFLEX INC","ticker":"TFX","form_type":"8-K","filed_at":"2026-06-09T21:13:16+00:00","items":["5.02"],"status":"ready","headline":"Teleflex awards $600K special RSU to Interim CEO Stuart Randle for extended service","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Special restricted stock unit award with grant-date fair value of $600,000 to Interim CEO Stuart A. Randle.","Grant date June 8, 2026; vests on earlier of June 8, 2027 or 2027 annual meeting.","Award recognizes Randle's contributions in operations, governance, investor relations, and CEO search.","Intended to acknowledge that Randle served as Interim CEO longer than initially expected."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":5757783520.587611,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":786956,"accession_number":"0001193125-26-251951","cik":96943,"company_name":"TELEFLEX INC","ticker":"TFX","form_type":"8-K","filed_at":"2026-06-01T22:35:49+00:00","items":["8.01","9.01"],"status":"ready","headline":"Teleflex prices $500M 5.875% senior notes due 2032 to refinance 2027 notes","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Priced $500M aggregate principal of 5.875% senior notes due 2032 at 100% of par.","Net proceeds plus cash on hand to redeem all outstanding 4.625% Senior Notes due 2027.","Offering expected to close June 15, 2026, subject to customary closing conditions.","Notes guaranteed by certain domestic subsidiaries; offered privately to QIBs and non-U.S. persons."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":5757783520.587611,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":759725,"accession_number":"0001193125-26-249764","cik":96943,"company_name":"TELEFLEX INC","ticker":"TFX","form_type":"8-K","filed_at":"2026-06-01T11:59:04+00:00","items":["7.01","8.01","9.01"],"status":"ready","headline":"Teleflex announces $500M senior notes offering to refinance 2027 notes","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Teleflex commenced offering of $500M senior notes due 2032; proceeds plus cash to redeem all $500M of 4.625% notes due 2027.","Offering is private Rule 144A/Reg S; interest rate and terms to be set at pricing.","Exhibit 99.2 shows FY2025 adjusted EBITDA of $530.9M from continuing ops ($906.2M total); proforma EBITDA $650.7M.","As of March 31, 2026, pro forma total debt after offering would be $2.825B; company also executed $1.0B share repurchase program."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":5757783520.587611,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":698116,"accession_number":"0001193125-26-242184","cik":96943,"company_name":"TELEFLEX INC","ticker":"TFX","form_type":"8-K","filed_at":"2026-05-27T21:23:02+00:00","items":["1.01","2.03","9.01"],"status":"ready","headline":"Teleflex enters $2.2B new credit facilities; $1B revolver and $1.2B term loans","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Entered new $1B revolver, $500M term A-1, and $700M term A-2 credit facilities; refinances prior credit agreement.","Revolving and term A-1 mature May 26, 2031; term A-2 matures May 26, 2028.","Interest: Term SOFR + 1.125%-2.00% or base rate + 0.125%-1.00%; max total net leverage 4.50x, min interest coverage 3.00x.","Covenants include limitations on additional debt, liens, investments, and restricted payments, with exceptions for acquisitions and dispositions.","Agreement references pending Acute Care Disposition and OEM Disposition, affecting certain thresholds and amounts."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":5757783520.587611,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":554685,"accession_number":"0000096943-26-000068","cik":96943,"company_name":"TELEFLEX INC","ticker":"TFX","form_type":"8-K","filed_at":"2026-05-20T20:14:35+00:00","items":["5.07"],"status":"ready","headline":"Teleflex stockholders re-elect all seven directors and approve say-on-pay at 2026 annual meeting","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["All seven director nominees received >96% of votes cast (excluding broker non-votes).","Advisory vote on executive compensation passed with ~96% support (38,990,583 for, 1,632,219 against).","Ratification of PwC as independent auditor for 2026 approved with ~95% of votes cast (40,460,649 for).","No contested items; all proposals passed with substantial majorities.","Broker non-votes noted on director elections and say-on-pay, but not on auditor ratification."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.15,"market_cap_usd":5757783520.587611,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":100002,"accession_number":"0000096943-26-000048","cik":96943,"company_name":"TELEFLEX INC","ticker":"TFX","form_type":"8-K","filed_at":"2026-05-07T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Teleflex Q1 revenue up 5.1% pro forma; GAAP EPS $(0.11); maintains FY26 guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue from continuing ops $548.3M, up 32.3% reported, +5.1% pro forma adjusted constant currency.","GAAP diluted EPS from continuing ops $(0.11) vs $1.14 prior year; adjusted diluted EPS $1.39 vs $1.44.","FY26 guidance reaffirmed: GAAP rev growth 14.4%-15.4%, adjusted EPS $6.25-$6.55, including $90M stranded costs.","Jason Weidman appointed President and CEO effective June 8, 2026; $1B share repurchase program and $800M debt paydown planned.","Strategic divestitures of Acute Care, Interventional Urology, and OEM businesses expected to close H2 2026."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.18,"consensus_revenue_estimate":null,"consensus_revenue_actual":548262000.0,"consensus_period":"2026-Q1","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":5757783520.587611,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":100001,"accession_number":"0000096943-26-000042","cik":96943,"company_name":"TELEFLEX INC","ticker":"TFX","form_type":"8-K","filed_at":"2026-04-30T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Teleflex appoints Jason Weidman as President and CEO effective June 8, 2026","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Weidman succeeds interim CEO Stuart Randle, who remains on the board; Weidman to join board on start date.","Weidman previously SVP and President at Medtronic, leading coronary & renal denervation and aortic/peripheral/venous units.","Compensation includes $1M base salary, 125% target bonus, $7M annual equity target (from 2027), $7M sign-on RSUs (4-yr vest), and $1M stock options (3-yr vest).","Eligible for up to $800K cash payment to replace forfeited incentive from prior employer and relocation benefits.","Chairman cites $1B share buyback and $800M debt paydown intended after close of sale transactions as part of transformation."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":5757783520.587611,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":116331,"accession_number":"0000096943-26-000036","cik":96943,"company_name":"TELEFLEX INC","ticker":"TFX","form_type":"8-K","filed_at":"2026-03-27T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Teleflex responds to Irenic; reaffirms $1.8B sale proceeds for $1B buyback, $800M debt paydown, $50M cost savings","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Sale transactions of Acute Care, Interventional Urology, and OEM on track for H2 2026 close.","Expected net proceeds of ~$1.8B after tax to fund $1.0B share repurchase and $800M debt paydown.","Multi-year restructuring targets ~$50M annual pre-tax cost savings by mid-2028.","Board has not rebuffed acquirer approaches; will consider bona fide proposals.","CEO search ongoing; interim CEO Stu Randle leading restructuring plan."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":5757783520.587611,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":116330,"accession_number":"0000096943-26-000031","cik":96943,"company_name":"TELEFLEX INC","ticker":"TFX","form_type":"8-K","filed_at":"2026-03-17T23:59:59+00:00","items":["8.01"],"status":"ready","headline":"Teleflex updates on OEM and Acute Care divestitures; FTC Second Request for urology deal","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["OEM HSR waiting period expired March 13, 2026; closing anticipated in Q3 2026.","Acute Care and Urology deal received FTC Second Request on March 11, extending HSR review.","Company and Intersurgical cooperating with FTC; close expected in H2 2026.","Both transactions, announced Dec 9, 2025, are separate and subject to other conditions."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":5757783520.587611,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":116329,"accession_number":"0000096943-26-000011","cik":96943,"company_name":"TELEFLEX INC","ticker":"TFX","form_type":"8-K","filed_at":"2026-02-26T23:59:59+00:00","items":["2.02","7.01","2.05","9.01"],"status":"ready","headline":"Teleflex reports FY2025 adjusted EPS $6.98; FY2026 guidance $6.25-$6.55; restructuring plan saves $48M-$52M annually","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["GAAP revenue from continuing ops $1,992.7M (+17.2% YoY); adjusted revenue $1,983.7M (+16.3%).","GAAP diluted EPS from continuing ops $1.31 (vs $1.21); adjusted diluted EPS $6.98 (vs $6.42).","FY2026 guidance: pro forma adjusted constant currency revenue growth 4.5%-5.5%; adjusted EPS $6.25-$6.55, down from $6.98.","Restructuring plan approved: $31M-$37M total charges, annual pre-tax savings $48M-$52M, substantially complete by mid-2028.","Strategic divestitures expected close H2 2026; ~$1.8B after-tax proceeds; $1B share repurchase authorized."],"consensus_eps_estimate":null,"consensus_eps_actual":-20.25,"consensus_revenue_estimate":null,"consensus_revenue_actual":1992713000.0,"consensus_period":"2025-FY","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":5757783520.587611,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":116328,"accession_number":"0000096943-26-000006","cik":96943,"company_name":"TELEFLEX INC","ticker":"TFX","form_type":"8-K","filed_at":"2026-01-23T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Teleflex enters separation agreement with ex-CEO Kelly; transition period through March 2026","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["CEO Liam Kelly departed Jan 7, 2026; separation agreement signed Jan 23, 2026.","Kelly resigned from Board effective Jan 23, 2026.","Transition period through March 31, 2026 for transition services.","During transition, Kelly receives base salary, benefits, 2025 bonus when paid, and vesting of equity awards scheduled during transition.","Kelly remains subject to restrictive covenants from existing severance agreement."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":5757783520.587611,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":116327,"accession_number":"0000096943-26-000003","cik":96943,"company_name":"TELEFLEX INC","ticker":"TFX","form_type":"8-K","filed_at":"2026-01-08T23:59:59+00:00","items":["2.02","5.02","9.01"],"status":"ready","headline":"Teleflex CEO Liam Kelly out, interim CEO Stuart Randle appointed; 2025 revenue guide cut","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Liam Kelly departs as President and CEO effective Jan 7, 2026; Stuart Randle appointed interim CEO.","Dr. Stephen Klasko named independent Board Chair; Spencer Stuart engaged for permanent CEO search.","Preliminary FY2025 revenue $3.270B–$3.278B, below prior guidance of $3.305B–$3.320B.","Revenue shortfall driven by softer demand for intra-aortic balloon pumps/catheters and order delays."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":5757783520.587611,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":132792,"accession_number":"0001193125-25-312941","cik":96943,"company_name":"TELEFLEX INC","ticker":"TFX","form_type":"8-K","filed_at":"2025-12-09T23:59:59+00:00","items":["1.01","7.01","8.01","9.01"],"status":"ready","headline":"Teleflex sells Acute Care, Interventional Urology, and OEM businesses for $2.03B; authorizes $1B buyback","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Total cash consideration $2.03B: OEM business to Montagu/Kohlberg for $1.5B; Acute Care and Interventional Urology to Intersurgical for $530M.","Net after-tax proceeds expected ~$1.8B; primarily used for share repurchases and debt reduction.","Board authorized $1B share repurchase program, funded from transaction proceeds.","Transactions expected to close in H2 2026, subject to regulatory approvals and customary conditions.","Teleflex will focus on remaining core businesses: Vascular Access, Interventional, and Surgical, targeting mid-single-digit growth."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":5757783520.587611,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":132791,"accession_number":"0000096943-25-000136","cik":96943,"company_name":"TELEFLEX INC","ticker":"TFX","form_type":"8-K","filed_at":"2025-11-06T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Teleflex Reports Q3 2025 Revenue Growth but GAAP Loss; Lowers Full-Year Guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["GAAP revenue $913.0M up 19.4% YoY; adjusted revenue $892.9M up 16.8% (adjusted constant currency up 15.3%).","GAAP diluted EPS from continuing operations $(9.24) vs $2.36 prior year; adjusted diluted EPS $3.67 vs $3.49.","Full-year 2025 guidance: GAAP revenue growth narrowed to 9.1%-9.6%; adjusted constant currency revenue growth lowered to 6.9%-7.4%.","GAAP EPS from continuing operations guidance lowered to $(4.42)-$(4.22); adjusted EPS narrowed to $14.00-$14.20.","Company continues separation into RemainCo and NewCo; potential sale of NewCo is primary focus."],"consensus_eps_estimate":null,"consensus_eps_actual":-4.27,"consensus_revenue_estimate":null,"consensus_revenue_actual":2394579000.0,"consensus_period":"2025-Q3","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":5757783520.587611,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":149327,"accession_number":"0000096943-25-000112","cik":96943,"company_name":"TELEFLEX INC","ticker":"TFX","form_type":"8-K","filed_at":"2025-07-31T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Teleflex Q2 adj. EPS $3.73 beats $3.42 YoY; raises FY outlook on BIOTRONIK deal","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["GAAP revenue $780.9M (+4.2% YoY); adjusted constant currency revenue growth +1.0%.","GAAP diluted EPS $2.77 vs $1.69; adjusted diluted EPS $3.73 vs $3.42.","Full-year GAAP revenue growth guidance raised to 9.0%-10.0% (from 1.3%-2.3%) due to BIOTRONIK acquisition.","FY adjusted diluted EPS guidance raised to $13.90-$14.30 from $13.20-$13.60.","Interventional segment revenue surged 20.4% as reported; OEM and Interventional Urology each declined over 8%."],"consensus_eps_estimate":null,"consensus_eps_actual":4.82,"consensus_revenue_estimate":null,"consensus_revenue_actual":1481558000.0,"consensus_period":"2025-Q2","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":5757783520.587611,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":168360,"accession_number":"0000096943-25-000107","cik":96943,"company_name":"TELEFLEX INC","ticker":"TFX","form_type":"8-K","filed_at":"2025-06-30T23:59:59+00:00","items":["1.01","2.03","9.01"],"status":"ready","headline":"Teleflex increases delayed draw term loan facility by $200M to $700M for Vascular Intervention acquisition","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Amendment to Credit Agreement added $200M in delayed draw term loans, bringing total commitments to $700M.","Funds available upon consummation of the acquisition of MS Holding II SE's Vascular Intervention business.","Amendment dated June 24, 2025, with JPMorgan Chase Bank as administrative agent and several lenders.","No material changes to other terms of the credit agreement beyond the commitment increase."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":5757783520.587611,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":168359,"accession_number":"0000096943-25-000099","cik":96943,"company_name":"TELEFLEX INC","ticker":"TFX","form_type":"8-K","filed_at":"2025-05-15T23:59:59+00:00","items":["5.03","5.07","9.01"],"status":"ready","headline":"Teleflex amends bylaws to allow stockholder written consent; annual meeting votes pass","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Bylaws amended to remove prohibition on stockholder action by written consent, effective May 9, 2025.","All nine director nominees elected; highest against votes for Stephen K. Klasko (14.1M against).","Advisory say-on-pay approved: 29.0M for, 10.4M against.","Ratification of PwC as auditor for 2025 approved: 39.7M for, 1.4M against.","Stockholder proposal to lower special meeting holding requirement defeated: 4.6M for, 34.8M against."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":5757783520.587611,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":168358,"accession_number":"0000096943-25-000074","cik":96943,"company_name":"TELEFLEX INC","ticker":"TFX","form_type":"8-K","filed_at":"2025-05-01T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Teleflex Q1 adjusted EPS $2.91 (down 9.3% YoY); cuts FY adjusted EPS guidance to $13.20-$13.60 on $55M tariff hit","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q1 revenue $700.7M (-5.0% reported, -3.8% adj constant currency); GAAP EPS $2.07, adjusted EPS $2.91 (down from $3.21).","FY2025 adjusted EPS guidance cut to $13.20-$13.60 (from $13.95-$14.35) on $55M tariff hit; partially offset by $300M buyback.","Completed $300M accelerated share repurchase on April 9; also exploring potential sale of NewCo in parallel with spin separation.","Segment weakness: OEM -26.8%, Interventional Urology -10.7%, Anesthesia -8.6% adj constant currency; Interventional +3.2% growth."],"consensus_eps_estimate":null,"consensus_eps_actual":2.07,"consensus_revenue_estimate":null,"consensus_revenue_actual":700669000.0,"consensus_period":"2025-Q1","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":5757783520.587611,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":185532,"accession_number":"0000096943-25-000033","cik":96943,"company_name":"TELEFLEX INC","ticker":"TFX","form_type":"8-K","filed_at":"2025-03-04T23:59:59+00:00","items":["8.01"],"status":"ready","headline":"Teleflex enters $300M accelerated share repurchase agreement with JPMorgan","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Entered $300M ASR with JPMorgan; initial delivery of shares worth 80% of repurchase price based on Feb 27 close.","Final share count based on VWAP during ASR term, less discount; settlement due in Q2 2025 or earlier.","Repurchase funded by revolving credit borrowings under existing senior credit facility.","Part of previously announced $500M share repurchase program."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":5757783520.587611,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":185531,"accession_number":"0000096943-25-000025","cik":96943,"company_name":"TELEFLEX INC","ticker":"TFX","form_type":"8-K","filed_at":"2025-02-27T23:59:59+00:00","items":["1.01","2.03","2.02","5.02","7.01","9.01"],"status":"ready","headline":"Teleflex reports Q4 adj EPS $3.89 (+15%); plans two-company split and BIOTRONIK acquisition","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Q4 GAAP EPS from cont. ops. $(2.95) vs $0.66; adj EPS $3.89 vs $3.38 (+15.1%). Full-year adj EPS $14.01.","2025 guidance: adj EPS $13.95-$14.35; adj constant currency revenue growth 1%-2%.","Plans tax-free separation into RemainCo (Vascular Access, Interventional, Surgical) and NewCo (Urology, Acute Care, OEM); completion expected mid-2026.","Definitive agreement to acquire substantially all of BIOTRONIK's Vascular Intervention business; $500M delayed draw term loan facility secured.","CFO Thomas Powell retiring Apr 1, 2025; John R. Deren succeeds as EVP & CFO effective Apr 2, consulting for one year."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":5757783520.587611,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":202119,"accession_number":"0000096943-24-000146","cik":96943,"company_name":"TELEFLEX INC","ticker":"TFX","form_type":"8-K","filed_at":"2024-10-31T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Teleflex Q3 GAAP EPS $2.36, adj $3.49; cuts FY revenue growth guidance to 2.9-3.4%","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q3 GAAP revenue $764.4M, +2.4% YoY; GAAP diluted EPS $2.36 vs $2.91; adjusted diluted EPS $3.49 vs $3.64.","Lowers FY2024 GAAP revenue growth guidance to 2.90%-3.40% (from 3.40%-4.40%); adjusted constant currency growth guidance cut to 3.5%-4.0%.","Raises FY2024 GAAP EPS guidance to $6.65-$6.95 (from $6.43-$6.83); adjusted EPS guidance $13.90-$14.20.","Interventional Urology (+13.3%) and Interventional (+11.8%) drove growth; OEM soft at +0.3%; Other category fell 28% due to Italian payback reserve.","Board authorized $500M share repurchase; $200M accelerated share program in Q3; net leverage 1.7x."],"consensus_eps_estimate":null,"consensus_eps_actual":4.37,"consensus_revenue_estimate":null,"consensus_revenue_actual":2251915000.0,"consensus_period":"2024-Q3","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":5757783520.587611,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":218156,"accession_number":"0000096943-24-000140","cik":96943,"company_name":"TELEFLEX INC","ticker":"TFX","form_type":"8-K","filed_at":"2024-08-29T23:59:59+00:00","items":["8.01"],"status":"ready","headline":"Teleflex CFO adopts 10b5-1 plan for up to 53,754 shares starting Dec 2024","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["CFO Thomas Powell entered a 10b5-1 trading plan allowing sale of up to 53,754 shares.","Shares represent ~31% of Powell's total holdings including options and RSUs.","Sales begin December 2024; may extend to November 2025 if minimum price thresholds unmet.","Plan is for financial planning purposes; shares acquired via exercised stock options."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"market_cap_usd":5757783520.587611,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":218155,"accession_number":"0000096943-24-000134","cik":96943,"company_name":"TELEFLEX INC","ticker":"TFX","form_type":"8-K","filed_at":"2024-08-05T23:59:59+00:00","items":["8.01"],"status":"ready","headline":"Teleflex enters $200M accelerated share repurchase with Bank of America, scheduled to conclude Q4 2024","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Paid $200M to Bank of America on Aug 5, 2024, for initial delivery of shares valued at 80% of repurchase price based on Aug 1 closing price.","Final repurchase quantity will be determined by volume-weighted average prices during the ASR term, with potential additional shares or cash adjustment.","Funded with revolving credit borrowings under existing senior credit facility and cash on hand.","Part of previously announced $500M share repurchase program; ASR expected to terminate in Q4 2024."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":5757783520.587611,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":218154,"accession_number":"0000096943-24-000128","cik":96943,"company_name":"TELEFLEX INC","ticker":"TFX","form_type":"8-K","filed_at":"2024-08-01T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Teleflex Q2 adjusted revenue $763.5M (+2.7%); raises FY adj EPS guidance to $13.80-$14.20","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["GAAP revenue $749.7M (+0.9% YoY); adjusted revenue $763.5M (+2.7% YoY, +3.4% constant currency).","GAAP diluted EPS $1.69 vs $2.35 prior; adjusted diluted EPS $3.42 vs $3.41 prior.","Raises FY adjusted constant currency revenue growth guidance to 4.25%-5.25%; lowers GAAP EPS guidance to $6.43-$6.83.","Board authorized $500M share repurchase program, including $200M accelerated share repurchase.","CEO cites strong Barrigel momentum and Palette Life Sciences integration on track."],"consensus_eps_estimate":null,"consensus_eps_actual":2.01,"consensus_revenue_estimate":null,"consensus_revenue_actual":1487540000.0,"consensus_period":"2024-Q2","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":5757783520.587611,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":238119,"accession_number":"0000096943-24-000078","cik":96943,"company_name":"TELEFLEX INC","ticker":"TFX","form_type":"8-K","filed_at":"2024-05-09T23:59:59+00:00","items":["5.02","5.07","8.01"],"status":"ready","headline":"Teleflex CEO Liam Kelly adopts 10b5-1 plan to sell up to 36,464 shares (9% of holdings)","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["CEO Liam Kelly entered Rule 10b5-1 plan to sell up to 36,464 shares acquired via options expiring 2025; sales in Nov and Dec 2024.","Compensation Committee approved salary increase for VP James Winters to $474,181 from $421,500, plus $200,000 equity grant (55% options, 25% RSUs, 20% PSUs).","At annual meeting, all six director nominees elected, say-on-pay approved (~93% for), shareholder proposal to lower special meeting threshold defeated."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"market_cap_usd":5757783520.587611,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":238118,"accession_number":"0000096943-24-000068","cik":96943,"company_name":"TELEFLEX INC","ticker":"TFX","form_type":"8-K","filed_at":"2024-05-02T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Teleflex Q1 revenue $737.8M (+3.8% YoY); adjusted EPS $3.21 vs $3.09; raises FY adjusted EPS low end","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["GAAP diluted EPS from continuing ops $0.33 vs $1.63 prior year, reflecting $1.69 pension settlement charge.","Adjusted diluted EPS $3.21 vs $3.09; GAAP revenue growth guidance lowered to 3.35%-4.35% due to FX impact.","Constant currency revenue growth guidance reiterated at 3.75%-4.75%; GAAP EPS guidance raised to $6.87-$7.22.","Segment: Americas -1.4%, EMEA +11.4%, Asia +7.0%, OEM +13.9%; Interventional +15.2%, Other -26.7% from product disc.","Cash $237.4M; inventory $627.9M; D&A $66.9M for Q1."],"consensus_eps_estimate":null,"consensus_eps_actual":0.32,"consensus_revenue_estimate":null,"consensus_revenue_actual":737849000.0,"consensus_period":"2024-Q1","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":5757783520.587611,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":255587,"accession_number":"0000096943-24-000027","cik":96943,"company_name":"TELEFLEX INC","ticker":"TFX","form_type":"8-K","filed_at":"2024-02-22T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Teleflex Reports Q4 2023 Revenue of $773.9M, Full Year Revenue $2,974.5M; Provides 2024 Guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 GAAP diluted EPS from continuing operations was $0.66, down from $1.65 in prior year; adjusted EPS was $3.38 vs $3.52.","Full year constant currency revenue growth of 6.5% driven by Asia (+17.6%) and OEM (+18.9%) segments.","2024 adjusted diluted EPS guidance range of $13.55 to $13.95, representing 0.2% to 3.2% year-over-year growth.","Cash and cash equivalents at Dec 31, 2023 were $222.8 million, down from $292.0 million a year earlier."],"consensus_eps_estimate":null,"consensus_eps_actual":7.53,"consensus_revenue_estimate":null,"consensus_revenue_actual":2974489000.0,"consensus_period":"2023-FY","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.9,"calibrated_materiality_score":0.9,"market_cap_usd":5757783520.587611,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":273039,"accession_number":"0000096943-23-000099","cik":96943,"company_name":"TELEFLEX INC","ticker":"TFX","form_type":"8-K","filed_at":"2023-11-02T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Teleflex Reports Q3 2023 Revenue of $746.4M, Up 8.7%, Raises Full Year Guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Third quarter revenue $746.4M, up 8.7% reported and 7.4% constant currency year-over-year.","GAAP diluted EPS from continuing operations $2.91, compared to $2.16 in prior year period.","Adjusted diluted EPS from continuing operations $3.64, up from $3.27 in prior year period.","Raises constant currency revenue growth guidance to 6.4%–6.6% for full year 2023.","Completed acquisition of Palette Life Sciences AB, and terminated Medline manufacturing transition services agreement."],"consensus_eps_estimate":null,"consensus_eps_actual":6.88,"consensus_revenue_estimate":null,"consensus_revenue_actual":2200580000.0,"consensus_period":"2023-Q3","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":5757783520.587611,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":289877,"accession_number":"0000096943-23-000094","cik":96943,"company_name":"TELEFLEX INC","ticker":"TFX","form_type":"8-K","filed_at":"2023-08-31T23:59:59+00:00","items":["8.01"],"status":"ready","headline":"Teleflex seeks court validation of 2023 stockholder actions due to record date error; hearing Sept 18","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["Filed DGCL Section 205 petition to validate stockholder votes eliminating supermajority and approving 2023 Stock Incentive Plan.","Record date March 3, 2023 was 63 days pre-meeting, exceeding 60-day max; should have been March 6, 2023.","Court of Chancery set expedited hearing on September 18, 2023 at 11:30 a.m. ET in Dover, DE.","Stockholders may appear at hearing or file written submissions before hearing.","If validation fails, stockholder actions could be invalidated, causing adverse effects."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":5757783520.587611,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":289876,"accession_number":"0000096943-23-000088","cik":96943,"company_name":"TELEFLEX INC","ticker":"TFX","form_type":"8-K","filed_at":"2023-08-03T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Teleflex Q2 revenue up 5.9% constant currency; revenue guidance raised, adjusted EPS maintained","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q2 revenues $743.3M, +5.9% constant currency YoY; GAAP diluted EPS $2.35, adjusted diluted EPS $3.41.","FY2023 GAAP revenue growth guidance raised to 5.80%-6.55%; constant currency raised to 5.50%-6.25%.","FY2023 GAAP diluted EPS guidance lowered to $7.33-$7.93; adjusted diluted EPS maintained at $13.00-$13.60.","Announced acquisition of Palette Life Sciences AB for rectal spacer to expand Interventional Urology franchise.","Interventional Urology constant currency revenue declined 2.3% YoY; OEM segment grew 19.8% constant currency."],"consensus_eps_estimate":null,"consensus_eps_actual":3.98,"consensus_revenue_estimate":null,"consensus_revenue_actual":1454191000.0,"consensus_period":"2023-Q2","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":5757783520.587611,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":310820,"accession_number":"0000096943-23-000052","cik":96943,"company_name":"TELEFLEX INC","ticker":"TFX","form_type":"8-K","filed_at":"2023-05-11T23:59:59+00:00","items":["5.03","5.07","9.01"],"status":"ready","headline":"Teleflex shareholders approve elimination of supermajority voting provisions","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Shareholders voted 41.6M for, 175k against to amend certificate of incorporation, eliminating supermajority voting.","Three directors elected: Gretchen Haggerty, Liam Kelly, Jaewon Ryu with votes for ranging 39.7M–41.7M.","Advisory vote on executive compensation received 39.1M for (93.6% of votes cast); annual say-on-pay adopted.","Shareholder proposal for special meeting right defeated: 11.4M for, 30.2M against.","Teleflex 2023 Stock Incentive Plan approved with 39.2M for, 2.6M against."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.35,"calibrated_materiality_score":0.35,"market_cap_usd":5757783520.587611,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":310819,"accession_number":"0000096943-23-000047","cik":96943,"company_name":"TELEFLEX INC","ticker":"TFX","form_type":"8-K","filed_at":"2023-05-04T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Teleflex Q1: revenue $710.9M (+13.2% cc), adj. EPS $3.09; FY revenue guidance raised to 5.00-6.25% cc","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $710.9M, up 10.8% reported (+13.2% constant currency); growth across all global product categories.","GAAP diluted EPS $1.63 (flat YoY); adjusted diluted EPS $3.09, up from $2.88 in prior year.","Full-year 2023 GAAP revenue growth guidance raised to 4.65%-5.90%; constant currency growth raised to 5.00%-6.25%.","Full-year GAAP EPS guidance lowered to $8.14-$8.74; adjusted EPS guidance reiterated at $13.00-$13.60.","Cash and equivalents $264.1M; inventories $614.1M; strong start to 2023."],"consensus_eps_estimate":null,"consensus_eps_actual":1.62,"consensus_revenue_estimate":null,"consensus_revenue_actual":710932000.0,"consensus_period":"2023-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":5757783520.587611,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":329440,"accession_number":"0000096943-23-000041","cik":96943,"company_name":"TELEFLEX INC","ticker":"TFX","form_type":"8-K","filed_at":"2023-03-24T23:59:59+00:00","items":["8.01"],"status":"ready","headline":"CEO Liam J. Kelly adopts 10b5-1 plan to sell up to 26,256 TFX shares","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Plan covers sale of up to 26,256 shares acquired via stock option exercise, ~6.9% of Kelly's total holdings.","Sales scheduled in two tranches: November 2023 and December 2023, on the open market at minimum price thresholds.","Underlying options are scheduled to expire in 2024; plan complies with Rule 10b5-1.","Remaining unsold shares may be sold through December 2023 if minimum price thresholds are not met initially."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":5757783520.587611,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":329439,"accession_number":"0000096943-23-000019","cik":96943,"company_name":"TELEFLEX INC","ticker":"TFX","form_type":"8-K","filed_at":"2023-02-23T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Teleflex Q4 2022 revenue $758M, adjusted EPS $3.52; guides 2023 adjusted EPS $13.00-$13.60","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 revenue $758.0M (-0.5% reported, +3.7% constant currency); GAAP EPS $1.65, adjusted EPS $3.52.","Full year 2022 revenue $2,791.0M (-0.7% reported, +2.9% constant currency); GAAP EPS $7.67, adjusted EPS $13.06.","2023 guidance: constant currency revenue growth 4.75%-6.25%; adjusted EPS $13.00-$13.60 (flat to +4.1% YoY).","Completed acquisition of Standard Bariatrics in Q4; cash and equivalents $292M at year-end."],"consensus_eps_estimate":null,"consensus_eps_actual":7.68,"consensus_revenue_estimate":null,"consensus_revenue_actual":2791041000.0,"consensus_period":"2022-FY","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":5757783520.587611,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":347034,"accession_number":"0000096943-22-000108","cik":96943,"company_name":"TELEFLEX INC","ticker":"TFX","form_type":"8-K","filed_at":"2022-11-21T23:59:59+00:00","items":["2.05"],"status":"ready","headline":"Teleflex initiates restructuring plan with $31M-$40M charges; expects $21M-$23M annual savings","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Initiated 2022 restructuring plan on Nov 15, 2022; substantial completion expected during 2023.","Estimated pre-tax charges of $31M-$40M; $26M-$32M in cash outlays, mostly in 2023.","Plan includes relocating manufacturing to lower-cost locations and workforce reductions.","Expected annual pre-tax savings of $21M-$23M once fully implemented.","Capital expenditures of approx. $2M expected, mostly in 2023."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":5757783520.587611,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":347033,"accession_number":"0001193125-22-282591","cik":96943,"company_name":"TELEFLEX INC","ticker":"TFX","form_type":"8-K","filed_at":"2022-11-10T23:59:59+00:00","items":["1.01","9.01"],"status":"ready","headline":"Teleflex amends credit facility: $1B revolver and $500M term loan, maturity Nov 2027","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Third Amended and Restated Credit Agreement provides $1.0B revolving and $500M term loan facilities.","Facilities mature November 4, 2027, replacing the 2019 credit agreement.","Interest rates based on Term SOFR plus margin of 1.125%–2.00% or alternate base rate plus 0.125%–1.00%.","Covenants include maximum total net leverage ratio of 4.50x and minimum interest coverage ratio of 3.50x.","Obligations secured by substantially all assets of Teleflex and material domestic subsidiaries."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":5757783520.587611,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":347032,"accession_number":"0000096943-22-000102","cik":96943,"company_name":"TELEFLEX INC","ticker":"TFX","form_type":"8-K","filed_at":"2022-10-27T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Teleflex Q3 revenue down 1.9% YoY; cuts FY 2022 GAAP & adjusted EPS guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q3 revenue $686.8M (-1.9% reported; +2.4% constant currency); GAAP EPS $2.16 vs $4.20 prior.","Adjusted diluted EPS $3.27, down from $3.51; full-year adjusted EPS guidance lowered to $12.80-$13.20 from $13.00-$13.40.","GAAP revenue growth guidance lowered to (0.75)% to 0.25%; constant currency growth maintained at 3.25%-4.25%.","Acquired Standard Bariatrics during Q3; expects revenue and margin accretion over time.","Americas revenue -2.9% reported, Asia +9.4%; supply chain challenges persist but logistics stabilizing."],"consensus_eps_estimate":null,"consensus_eps_actual":6.01,"consensus_revenue_estimate":null,"consensus_revenue_actual":2033045000.0,"consensus_period":"2022-Q3","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":5757783520.587611,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":363414,"accession_number":"0000096943-22-000088","cik":96943,"company_name":"TELEFLEX INC","ticker":"TFX","form_type":"8-K","filed_at":"2022-07-28T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Teleflex Q2 revenue $704.5M (-1.3% YoY); FY2022 adjusted EPS guidance cut to $13.00-$13.40 from $13.70-$14.30","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $704.5M, down 1.3% YoY; constant currency growth +2.3%.","GAAP diluted EPS $2.23 vs $1.76 prior year; adjusted EPS $3.39 vs $3.35.","Interventional Urology revenue fell 13.5% YoY on constant currency basis.","FY2022 adjusted EPS guidance lowered to $13.00-$13.40 from $13.70-$14.30.","Constant currency revenue growth guidance reduced to 3.25%-4.25% from 4.0%-5.5%."],"consensus_eps_estimate":null,"consensus_eps_actual":3.86,"consensus_revenue_estimate":null,"consensus_revenue_actual":1346257000.0,"consensus_period":"2022-Q2","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":5757783520.587611,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":383225,"accession_number":"0000096943-22-000077","cik":96943,"company_name":"TELEFLEX INC","ticker":"TFX","form_type":"8-K","filed_at":"2022-06-03T23:59:59+00:00","items":["8.01"],"status":"ready","headline":"CEO Liam J. Kelly adopts 10b5-1 plan to sell up to 25,962 shares in Nov-Dec 2022","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Plan covers shares from option exercises and represents about 7.5% of Kelly's total holdings.","Sales scheduled in two tranches: November 2022 and December 2022, subject to minimum price thresholds.","Options underlying the plan are set to expire in 2023.","Plan adopted under Rule 10b5-1 while Kelly was not in possession of material nonpublic info."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":5757783520.587611,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":383224,"accession_number":"0000096943-22-000071","cik":96943,"company_name":"TELEFLEX INC","ticker":"TFX","form_type":"8-K","filed_at":"2022-05-20T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Teleflex reaffirms 2022 guidance, sets 2023-2025 goals: 6-7% revenue CAGR, 200-300 bps op margin expansion","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Reaffirmed 2022 GAAP revenue growth of 2.3%-3.8% (4.0%-5.5% constant currency) and GAAP EPS $8.85-$9.45; adjusted EPS $13.70-$14.30.","Set 2023-2025 goals: 6-7% compounded annual constant currency revenue growth from year-end 2022.","Targets adjusted gross margin expansion of 250-350 bps and adjusted operating margin expansion of 200-300 bps by year-end 2025.","Forecasts cumulative free cash flow of at least $1.7 billion for 2023-2025."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":5757783520.587611,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":383221,"accession_number":"0000096943-22-000067","cik":96943,"company_name":"TELEFLEX INC","ticker":"TFX","form_type":"8-K/A","filed_at":"2022-05-09T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"Teleflex files 8-K/A to correct typo in 2022 annual meeting vote results","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Amendment fixes typographical error in Proposal 5 description from the May 5, 2022 original 8-K.","Voting results for all five proposals remain unchanged from the previously reported figures.","Proposal 5 (stockholder proposal to amend limited voting requirements) received 37.6M for, 1.9M against.","All other proposals, including director elections and advisory vote on executive compensation, also unchanged."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.0,"calibrated_materiality_score":0.0,"market_cap_usd":5757783520.587611,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":383223,"accession_number":"0000096943-22-000065","cik":96943,"company_name":"TELEFLEX INC","ticker":"TFX","form_type":"8-K","filed_at":"2022-05-05T23:59:59+00:00","items":["5.03","5.07","9.01"],"status":"ready","headline":"Teleflex shareholders approve phased-in board declassification starting 2023","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["A&R Bylaws and Certificate of Incorporation effective May 2, 2022, declassifying board over three years.","Vote: 39.4M for (99.8% of votes cast) on declassification proposals; broker non-votes 1.8M.","All three director nominees elected: Heinmiller (38.99M for), Krakauer (33.28M for), Patil (39.44M for).","Advisory say-on-pay approved: 36.45M for, 3.04M against; ratification of PwC passed with 39.64M for.","Stockholder proposal on limited voting requirements also passed with 37.58M for."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":5757783520.587611,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":383222,"accession_number":"0000096943-22-000037","cik":96943,"company_name":"TELEFLEX INC","ticker":"TFX","form_type":"8-K","filed_at":"2022-04-28T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Teleflex Q1 revenue $641.7M (+1.2% YoY); adjusted EPS $2.88 flat; reaffirms 2022 adjusted EPS guidance $13.70-$14.30","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $641.7M, up 1.2% reported (3.2% constant currency); Surgical category grew 14.4% constant currency.","GAAP diluted EPS $1.63 vs $1.58; adjusted diluted EPS $2.88 vs $2.87, roughly flat YoY.","Full-year 2022 guidance: constant currency revenue growth 4.0%-5.5% and adjusted EPS $13.70-$14.30 reiterated; GAAP EPS revised to $8.85-$9.45 from $8.90-$9.50.","Americas segment $378M (+0.8% constant currency); EMEA revenue down 3.1% reported but up 3.4% constant currency due to forex headwinds."],"consensus_eps_estimate":null,"consensus_eps_actual":1.63,"consensus_revenue_estimate":null,"consensus_revenue_actual":641715000.0,"consensus_period":"2022-Q1","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":5757783520.587611,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":401019,"accession_number":"0000096943-22-000013","cik":96943,"company_name":"TELEFLEX INC","ticker":"TFX","form_type":"8-K","filed_at":"2022-02-25T23:59:59+00:00","items":["5.02","8.01"],"status":"ready","headline":"Director Packer to retire at 2022 annual meeting; Neena Patil nominated as independent director","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Richard A. Packer will not stand for reelection and will retire from the Board effective immediately before the 2022 annual meeting, due to potential overlap with Asahi Kasei.","Packer's retirement is not due to any disagreement with Teleflex on operations, policies or practices.","Neena M. Patil, Chief Legal Officer of Jazz Pharmaceuticals, nominated to stand for election as an independent director at the annual meeting."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"market_cap_usd":5757783520.587611,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":401018,"accession_number":"0000096943-22-000010","cik":96943,"company_name":"TELEFLEX INC","ticker":"TFX","form_type":"8-K","filed_at":"2022-02-24T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Teleflex Q4 revenue $761.9M (+7.1%), adj. EPS $3.60 (+10.8%); 2022 adj. EPS guidance $13.70-$14.30","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 reported revenues $761.9M, up 7.1% YoY; constant currency growth 7.9%.","GAAP diluted EPS from continuing ops $2.69 vs $1.62 prior year; adjusted EPS $3.60 up 10.8%.","FY2021 full-year revenues $2.81B, up 10.7% reported; constant currency growth 8.8%.","FY2022 guidance: GAAP revenue growth 2.3%-3.8%; constant currency growth 4.0%-5.5%.","FY2022 adjusted EPS guidance $13.70-$14.30, representing 2.8%-7.3% YoY increase."],"consensus_eps_estimate":null,"consensus_eps_actual":10.23,"consensus_revenue_estimate":null,"consensus_revenue_actual":2809563000.0,"consensus_period":"2021-FY","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":5757783520.587611,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null}],"next_cursor":"2022-02-24T23:59:59+00:00|401018"}